Press release
Dexcom Announces Dexcom ONE, the Newest Real-Time Continuous Glucose Monitoring System, to Its Range of Scan-Free and Fingerprick†-Free Devices
On the heels of the latest NICE guidelines, Dexcom ONE is in review by NHS England for addition to the Drug Tariff LONDON--(BUSINESS WIRE)-- DexCom, Inc.
About this update from Dexcom, Inc.
[{"type":"text","content":"\nOn the heels of the latest NICE guidelines, Dexcom ONE is in review by NHS England for addition to the Drug Tariff\n\n LONDON--(BUSINESS WIRE)--\nDexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the new Dexcom ONE Continuous Glucose Monitoring System will launch in the United Kingdom this May. The Dexcom ONE system is an easy-to-use real-time CGM (rt-CGM) that will be more affordable and accessible for people with diabetes in the UK. Dexcom ONE is currently in review to be added to drug tariffs across the UK regions.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220401005092/en/Dexcom ONE Product Family (Graphic: Business Wire)\nKaren Baxter, Vice President, UK & Ireland, Benelux, France and Spain at Dexcom: “The diabetes community represents a dynamic and inspiring group of individuals. It’s always been our priority to provide them with innovative and impactful technology. At Dexcom, we are constantly working to broaden access to CGM technologies that drive improved health outcomes. The upcoming launch of Dexcom ONE represents a significant step forward in diabetes management and inclusion on the drug tariff would ensure that more people benefit from this life changing technology. Should Dexcom ONE be added to the NHS drug tariff, Dexcom will implement an educational and support programme for people with diabetes and healthcare professionals to ensure the diabetes community can benefit as quickly as possible from reimbursement and wider availability of Dexcom CGM.”\n\nDexcom ONE, a wearable sensor and transmitter, puts people firmly in control of their diabetes. By continuously monitoring glucose levels and sending real-time values wirelessly to a compatible smart device* via the Dexcom ONE mobile app, the technology eliminates the need for painful fingerpricks.† The app was specially designed to be user friendly, displaying trend arrows to show the speed and direction glucose levels are heading, making in the moment treatment decisions easier. A range of customisable alerts help users avoid potentially dangerous high or low glucose events.\n\nThis news comes as the National Institute for Health and Care Excellence (NICE) announced new guidance for adults and children managing Type ...